ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 48 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,915,501 | +31.7% | 167,308 | +18.2% | 0.00% | – |
| Q2 2023 | $1,454,631 | +34.9% | 141,499 | +1.3% | 0.00% | – |
| Q1 2023 | $1,078,021 | +148592.6% | 139,672 | +41.4% | 0.00% | – |
| Q4 2022 | $725 | -99.8% | 98,807 | +92.3% | 0.00% | – |
| Q3 2022 | $370,000 | -15.3% | 51,370 | 0.0% | 0.00% | – |
| Q2 2022 | $437,000 | -8.2% | 51,370 | -3.2% | 0.00% | – |
| Q1 2022 | $476,000 | -35.2% | 53,064 | 0.0% | 0.00% | – |
| Q4 2021 | $735,000 | +36.6% | 53,064 | +5.4% | 0.00% | – |
| Q3 2021 | $538,000 | +31.9% | 50,364 | +11.2% | 0.00% | – |
| Q2 2021 | $408,000 | -15.0% | 45,300 | 0.0% | 0.00% | – |
| Q1 2021 | $480,000 | -20.9% | 45,300 | -5.9% | 0.00% | – |
| Q4 2020 | $607,000 | +43.5% | 48,154 | 0.0% | 0.00% | – |
| Q3 2020 | $423,000 | +7.4% | 48,154 | +18.7% | 0.00% | – |
| Q2 2020 | $394,000 | +198.5% | 40,554 | -11.8% | 0.00% | – |
| Q1 2020 | $132,000 | -25.4% | 45,997 | 0.0% | 0.00% | – |
| Q4 2019 | $177,000 | -1.7% | 45,997 | 0.0% | 0.00% | – |
| Q3 2019 | $180,000 | -1.6% | 45,997 | +5.7% | 0.00% | – |
| Q2 2019 | $183,000 | -36.0% | 43,512 | +4.4% | 0.00% | – |
| Q1 2019 | $286,000 | +104.3% | 41,667 | +9.4% | 0.00% | – |
| Q4 2018 | $140,000 | -41.9% | 38,089 | 0.0% | 0.00% | – |
| Q3 2018 | $241,000 | -2.8% | 38,089 | +16.1% | 0.00% | – |
| Q2 2018 | $248,000 | +110.2% | 32,819 | +122.2% | 0.00% | – |
| Q1 2018 | $118,000 | -28.5% | 14,767 | 0.0% | 0.00% | – |
| Q4 2017 | $165,000 | -3.5% | 14,767 | 0.0% | 0.00% | – |
| Q3 2017 | $171,000 | – | 14,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
| GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
| Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
| Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
| COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
| Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
| RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
| TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |